ID Company Parent Home PageLIPage Address City State Country

BPG001448Xortx Therapeutics https://wwhttps://ww4000, 421 Calgary AB Canada

BPG001656XP Pharma Consulting https://xp https://wwOne Broadw Cambridge MA US
BPG002076Xphyto https://xp https://wwSuite 270 –Vancouver BC Canada
BPG001448Xpress Biologics http://wwwhttps://wwAccessia PhMilmort Belgium Belgium
BPG001448XpressBio https://xpr https://ww4650 Wedge Frederick MD US
BPG001697Xspire Pharma http://www.xspirerx. PO Pox 172Madison MS US
BPG001776Xspray Pharma https://xs https://wwRasundavagSolna Sweden Sweden
BPG001878XtalPi https://wwhttps://wwTimes ScienShenzhen China China
BPG001878XtalPi https://wwhttps://ww7F, Tower BBeijing China China
BPG001878XtalPi https://wwhttps://ww4F, No.9 HuShenzhen China China
BPG001878XtalPi https://wwhttps://ww245 Main StCambridge MA US
BPG001448Xtant Medical https://xta https://ww664 CruiserBelgrade MT US
BPG001449XTL Biopharmaceuticalhttp://wwwhttps://ww5 HaCharoshet Raanana
St. Israel Israel
BPG001748XuanZhu Pharmaceutichttp://wwwhttps://wwHigh tech Shandong China China
BPG002046X-Vax Technology http://x-va https://www.linkedin Palm Beach Garden FL US
BPG001915XVir Therapeutics https://www.xvir.com/ Munich Germany Germany
BPG001449Xvivo Perfusion https://wwhttps://wwBox 53015 Göteborg Sweden Sweden
BPG001449XWPharma https://wwhttps://ww5th FI.,Bld Wuhan China China
BPG001449XWPharma https://wwhttps://ww19F-1, No. 9New Taipei City Taiwan Taiwan
BPG001899Xybion https://wwhttps://ww105 CollegePrinceton NJ US
BPG001899Xybion https://wwhttps://ww1st Floor, Chennai India India
BPG001899Xybion https://wwhttps://ww400 Jean-L Quebec City QC Canada
BPG001899Xybion https://wwhttps://wwHerriotstraFrankfurt Germany Germany
BPG001449XyloCor Therapeutics http://xylo https://www.linkedin. Philadelphia PA US
BPG001950Xylyx Bio https://xyl https://www.linkedin Brooklyn NY US
BPG001449Xynomic Pharmaceutichttps://xy https://ww3500 SouthDover DE US
BPG001449Xynomic Pharmaceutichttps://xy https://wwSuite 3306 Shanghai China China
BPG001950Xyntek CXV Globalhttps://wwhttps://ww11 Penns TrNewtown PA US
BPG001449Xyphos Astellas https://xyphosinc.com100 KimbalSouth SF CA US
BPG001450Y Biologics https://ybiologics.comTechno 4 RoDaejeon Korea Korea
BPG001450Yabao Pharmaceuticalhttp://wwwhttps://www.linkedin Beijing China China
BPG001727Yamo Pharmaceuticalshttps://www.yamopharma.com/ Columbus OH US
BPG001450Yao Pharm Fosun pha http://en. https://ww100 XingguChongqing China China
BPG001763Yaqrit https://yaqhttps://wwThe Elms C Ledbury UK UK
BPG002125Yarrow Biotechnology
BPG001450Yaso Therapeutics https://yas https://ww20860 N TaScottsdale AZ US
BPG001450Yecuris https://wwhttps://wwP.O. Box 4 Tualatin OR US
BPG001450YenZym Antibodies https://wwhttps://ww100 N Hill Brisbane CA US
BPG002137Yingli Pharma http://www.yl-pharmaRoom 01. 4tShanghai China China
BPG001947YishengBio http://yishengbio.com38 Yongda RBeijing China China
BPG001825Yiviva https://yiv https://ww447 Broad New York NY US
BPG001451YL Biologics https://www.ylbiologic12F, HamacTokyo Japan Japan
Zip Phone GenEmail Location Region
T2P 4K9 403 455-7727 info@xortxNA NA
2142 (617) 485-8693 EN US
V6J 3B1 780-818-6422 info@xphy NA NA
4041 32 (0) 4 346 00 20info@xpress-biologics EU
21703 301-228-2444 xpressbio@DC US
39110 601-990-9497 S US
16967 46 (0)8 730 37 00 info@xspraypharma.c EU
0755-86931536 AS
010-53604927 AS
0755-21005829 AS
2142 EN US
59714 888.886.9354 UC US
4365603 972-9-955-7080 info@xtlbi ML ML
25010 0531 80989300 AS
S US
EU
40014 46 (0)31 788 21 50 info@xvivoperfusion. EU
430079 AS
221 AS
8540 609-512-5790 JE US
600097 91-44-4283-3115 AS
G1K 8W1 418-525-0606 NA NA
60528 49 (0) 696 773 3456 EU
888-290-0081 JE US
JENY US
19901 650 430 7561 info@xyno DC US
200031 info@xynomicpharmaAS
18940 215-493-7091 sales@xyntJE US
94080 (650) 243-2951 CNSM US
34018 82-42-867-9971 AS
AS
MW US
401121 86 23 63211443 intl@yaopharma.com AS
HR8 1RZ EU

85260 (480) 771-4058 SW US

97062 503.352.4663 NW US
94005 650-583-1031 customers CNSM US
201203 (86)21-50200003 AS
86 400 603 4866 AS
10013 646 883 3906 hello@yivi JENY US
103-0007 AS
Business Type 1 Type 2 Type 3 Type 4 Type 5
Small Molecules SM
Drug Development Consulting CG
Drug formulations, diagnostics, drug delivery, psyc DI FD SM
Contract Production of Proteins & DNA for PreclinicaCM
Molecular Biology Products BB
Specialty Pharma SP GG
Technology for manufacturing amorphous variants EQ
AI Drug Design AI
AI Drug Design AI
AI Drug Design AI
AI Drug Design AI
Implants, Allografts, Surgical Products IM SR
Small Molecule, Biologic SM BP
Small Molecules SM
Herpes Vaccine VV BP
YB-1 dependent oncolytic adenoviruses for oncoly VI
Transplantation Systems SR
Small Molecules SM
Small Molecules SM
Cloud LIMS, Quality SO
Cloud LIMS, Quality SO
Cloud LIMS, Quality SO
Cloud LIMS, Quality SO
Gene Therapy DN
ECM substrate BB
Small Molecules SM
Small Molecules SM
Pharma, Device, Healthcare IT Consulting CG
Cell-based cancer therapies CE
Antibody Therapeutics AN BP
Various Branded Generics GG
Small Molecules for Autism SM
APIs, Generics SM AP
Liver Dialysis Device DV

Polymer drug SM
Murine-Derived Hepatocytes BB
Custom antibodies AN BB
Small Molecules SM
Vaccines VV
Biologic for oncology, chronic and inflammatory di BP
Biosimilars BS
Type 6 HQ (1=yes)Notes Lead Link Lead ProduClinical StaTher Area Date CheckDrug notesDrug Types
1 https://wwXRx-008 Clin2 Polycystic 03/24/22 XRx-101 CliNPH, INF
1
1
1
1
1
1
1
0
0
0
1 Holding company for X-Spine and Bacterin
1 http://www. hCDR1 Clin2 Systemic l 02/02/22 ErythropoieRHU, IMM,
1 http://wwwAnaprazoleClin3 (Chin Duodenal u05/10/21 Pipeline: INF, ONC, END, IMM, CVV
1
1
1
1 https://wwXW10172 Clin1 Sleep disor09/10/21 Also Clin1 ZZZ, NEU, P
0 https://wwXW10172 Clin1 Sleep disor09/10/21 Also Clin1 ZZZ, NEU, P
1
0
0
0
1 http://xylo XC001 Clin1/Clin2 Refractory 03/26/22 Also Clin0 CVV, X_X
1
1 Reverse-mehttps://xy AbexinostaClin3 Kidney can 02/09/22 Also 7 tria ONC
0 Reverse-mehttps://xy AbexinostaClin3 Kidney can 02/09/22 Also 7 tria ONC
1
1 Acquired byhttps://xypXYP-217 Clin0 NHL 12/17/21 XYP-317 RDONC
1 https://ybi YBL-006 Clin1 Immuno-on02/15/22 YBL-001 Cl ONC
1
1 https://w L1-79 Clin2 (fast Autism spe01/10/22 PSY
1
1
1 No website Dec 2021
1 Formerly inhttps://yas PPCM RD Contracept07/24/21 Also RD sexINF, OBG
1
1
1 http://wwwYY-20394 Clin3 cancers 01/26/22 YL-90148 ClONC, RHU, NPH
1 Website undhttp://yish YSJA RabiesCOM (ChinaRabies 10/05/21 PIKA rabiesVAC, INF,
1 https://yiv YIV-906 Clin2b Liver & pan08/23/21 UndisclosedONC, PSY, G
1 JV between Toyama & Lupin
 OwnershipFunding Financiers Ticker Exchange Year FoundEmployeesEmployeesFormat Contact Ch
U XRX CNSX 2012 1 10 FILN@xortx.com
R 1 10 FILN@xppha11/16/21
U XPHY CSE 2018 11 50
R 2014 11 50
R 2003 11 50 FN@xpress12/06/21
R 2011
U XSPRAY STO 2003 11 50
R $400M Aug 2021; $300M C Sep 2020 2014 200 500
R $400M Aug 2021; $300M C Sep 2020 2014 200 500
R $400M Aug 2021; $300M C Sep 2020 2014 200 500
R $400M Aug 2021; $300M C Sep 2020 2014 200 500
U XTNT OTC 1998 200 500 FILN@xtant01/14/22
U XTLB NASDAQ, Te1993 1 10 FILN@xtlbio.com
INF, ONC, END, IMM, CVV, HEP, URO, GI 200 500
R $56M A Jul 2019 2015 11 50 FILN@x-va 01/25/22
R 2008 1 10
U XVIPF OTC 1998 50 200 FN.LN@xvivoperfusion.com
R $40M Sep 2020; $17M B Sep 2017 2014 11 50 FN.LN@xwpharma.com
R $40M Sep 2020; $17M B Sep 2017 2014 11 50 FN.LN@xwpharma.com
R 1977 200 500 FILN@xybi 01/19/22
R 1977 200 500 FILN@xybion.com
R 1977 200 500 FILN@xybion.com
R 1977 200 500 FILN@xybion.com
R $41.9M A Mar 2021; $17M A Dec 2018 2013 11 50 FN.LN@xyl 02/18/22
R 2016 11 50 FN@xylyxb02/18/22
U XYNO NASDAQ 2016 11 50 FILN@xyno11/04/21
U XYNO NASDAQ 2016 11 50 FILN@xynomicpharma.com
R 1986 50 200 FNLI@xynte01/10/22
U (sub) 4503, ALP TYO, OTC 2017 1 10 FN@xyphos12/27/21
R 2007
U 600351 Shangahi 1978 1000 5000
R 2015 FILN@yamopharma.com
U (sub) 600196 Shanghai 1939 1000 5000
R 2014 11 50 FN.LN@yaqrit.com

R 2004 1 10 FILN@yasot03/21/22
R 2007 11 50 FNLN@yecu12/27/21
R 2006 1 10
ONC, RHU, NPH 2011
R $130M Feb 2021 1992
R 2014 1 10 FN@yiviva 03/29/22
R 2013 11 50
 First Name Last Name Job Title (1Email (1) First Name Last Name Job Title (2Email (2) First Name Last Name

Xiaoping Zhang CEO & PresREDACTED@xppharmaconsulting.com

Mo HashemzadPresident REDACTED@xpressbio.com

Michele Dolan Director of REDACTED@xtantmedical.com

Kip Wolf Head of Te REDACTED@x-vax.com

ivoperfusion.com
wpharma.com
wpharma.com
Steven Porfano CFO & EVP REDACTED@xybion.com

Al Gianchetti CEO & PresREDACTED@xylocor.com

John O'Neill CSO REDACTED@xylyxbio.com
Mark Xu CEO & PresREDACTED@xynomicpharma.com
omicpharma.com
Elliot Abreau SVP REDACTED@xyntekinc.com
Kaman Kim Director of REDACTED@xyphosinc.com

opharma.com

Mary Weitzel CEO & PresREDACTED@yasotherapeutics.com

Lander Foquet Staff ScientREDACTED@yecuris.com

Shwu-hueyLiu CSO & Co-FREDACTED@yiviva.com

Job Title (3Email (3)